Alcon, Inc. ALC delivered core earnings per share (EPS) of 81 cents for the third quarter of 2024, up 22.7% from the year-ago quarter’s figure (up 25% at the constant exchange rate or CER). The figure...
/CNW/ -- Recently the World Economic Forum released a report that highlights AI's potential to relieve pressure on healthcare systems worldwide, with Mayo...
Zimmer Biomet's ZBH strategic product launches and stabilizing market trends bolster our confidence in this stock. Yet, factors like macroeconomic uncertainties put pressure on the bottom line. The stock...
Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.81 in the fourth quarter of fiscal 2024, up 11.4% year over year. The figure topped the Zacks...
Catalent, Inc. CTLT reported first-quarter fiscal 2025 adjusted loss per share of 13 cents, flat year over year. The figure was wider than the Zacks Consensus Estimate of a loss of 11 cents per share....
Insulet’s PODD robust execution to expand the Omnipod 5 platform globally is a tailwind. The company is also capitalizing on the significant growth opportunities in the Type 2 diabetes space. PODD carries...
ResMed Inc.’s RMD adjusted earnings per share (EPS) in the first quarter of fiscal 2025 were $2.20, up 34.1% year over year. The metric beat the Zacks Consensus Estimate by 8.4%.The adjustments include...
Here are three attractive stocks to buy that will give you a healthy mix of growth and dividends.
For Immediate ReleaseChicago, IL – October 25, 2024 – Stocks in this week’s article are Leidos Holdings Inc. LDOS, NetApp NTAP, ResMed Inc. RMD, Trane Technologies TT and The Travelers Cos TRV.5...